Chester County News and Community Website
WEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI) announced the recent appointment of Dr. Jerry Huang, M.D., Ph.D. as the Senior Vice President of Clinical Development.
MTTI Announces the Appointment of Dr. Jerry Huang to the Clinical Team Read More WEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI), and its wholly owned subsidiary, Molecular Theranostic Center of Singapore (MTCS), announced the approval of a Clinical Trial Authorization (CTA) application …
Molecular Targeting Technologies and Molecular Theranostic Center of Singapore Gain Clinical Trial Authorization in Singapore Read More WEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI) announced promising results from a 1-year follow-up on EBTATE (2 cycles, 3.7 GBq/cycle) treatment of gastroenteropancreatic neuroendocrine tumors (GEP-NETs) without amino …
MTTI Highlights Promising One-Year Follow-Up on EBTATE Treatment of Neuroendocrine Cancer Patients Without Amino Acid Infusion Read More WEST CHESTER, PA — Molecular Targeting Technologies, Inc. (MTTI) announced favorable findings of a 3-year follow-up of EBTATE (3 cycles, 3.7 GBq/cycle) against metastatic gastroenteropancreatic neuroendocrine tumors (GEP-NETs). Results from …
MTTI Announces Favorable Three-Year Follow-Up for EBTATE in Neuroendocrine Tumors Read More